Muscle-specific kinase (MuSK) is a single-pass transmembrane protein that has a critical role in signaling between motor neurons and skeletal muscle. Anti-MuSK is an important marker in patients without anti-acetylcholine receptor antibodies in myasthenia gravis disease.
MuSK myasthenia gravis is a rare, severe autoimmune disease of the neuromuscular junction, only identified in 2001, with unclear pathogenic mechanisms. It is characterized by weakness that worsens with continued muscle work and improves with resting of the involved muscle(s). Non-immune genetic diseases of this synapse, referred to as congenital myasthenic syndromes, produce similar symptoms. The distribution of weakness is distinctive, involving primarily the extraocular muscles. In ocular MG, involvement is limited to these muscles. In more severe cases (generalized MG), the pontine- and bulbar-innervated muscles and the respiratory muscles are commonly also affected. Least frequently involved are the extremity muscles.
References:
Koneczny I, Cossins J, Vincent A. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. J Anat. 2014 Jan;224(1):29-35. doi: 10.1111/joa.12034. Epub 2013 Mar 4. PMID: 23458718; PMCID: PMC3867884.
Borges LS, Richman DP. Muscle-Specific Kinase Myasthenia Gravis. Front Immunol. 2020 May 8;11:707. doi: 10.3389/fimmu.2020.00707. PMID: 32457737; PMCID: PMC7225350.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.